Fibrillation auriculaire et prévention des AVC
Revu par Dr Hayley Willacy, FRCGP Dernière mise à jour par Dr Colin Tidy, MRCGPDernière mise à jour 19 déc. 2024
Respecte les directives éditoriales
- TéléchargerTélécharger
- Partager
- Language
- Discussion
- Ask Patient
- Version audio
- Ajouter aux sources préférées sur Google
Dans cette série :Fibrillation auriculaire
Les médicaments utilisés pour prévenir un AVC lié à la fibrillation auriculaire sont appelés anticoagulants. Ils aident à empêcher la formation de caillots sanguins dans vos vaisseaux sanguins.
En un coup d'œil
Atrial fibrillation (AF) can cause blood clots to form in the heart, leading to a stroke.
Strokes caused by AF are often more severe than other types of stroke.
Anticoagulant medicines can significantly reduce the risk of stroke in people with AF.
Your doctor uses a risk assessment, like the CHA2DS2-VASc score, to decide if you need medication.
Direct-acting oral anticoagulants (DOACs) are now preferred over warfarin for stroke prevention in AF.
Left atrial appendage occlusion surgery may be an option for those who cannot take anticoagulants.

Vous n'êtes pas sûr de mélanger des médicaments ?
Vérifiez les interactions possibles entre les médicaments, les compléments et les aliments avant de les prendre ensemble.
Why does atrial fibrillation increase your risk of having a stroke?
The main complication of atrial fibrillation (AF) est un increased risk of having a stroke. AF can interfere with the blood flow in the heart chambers. This sometimes leads to a small blood clot forming in a heart chamber.
A clot can travel in the blood vessels until it becomes stuck in a smaller blood vessel in the brain (or sometimes in another part of the body). Part of the blood supply to the brain may then be cut off, which causes a stroke. Strokes due to AF tend to be even more serious than strokes due to other causes.
The risk of developing a blood clot and having a stroke varies, depending on several factors. The level of risk can be calculated by your doctor using a set of specific questions. This will help to decide what treatments are required. All people except those at the lowest risk will be offered medication to help prevent clots from forming.
How can the risk of stroke be reduced?
Medicines called anticoagulants can be used to reduce the risk of a blood clot and so reduce the risk of stroke. Anticoagulants work by prolonging the time it takes for blood to form a clot. Some people call anticoagulation 'thinning the blood', although the blood is not actually made any thinner.
Anticoagulants reduce the risk of stroke by nearly two thirds. In other words, these treatments can prevent about 6 out of 10 strokes that would have occurred in people with AF.
Should you take medicine to reduce your risk of stroke?
Your doctor can use a risk assessment to see if you should take medicine to reduce your risk of stroke. The most commonly used risk assessment tool is called the CHA2DS2-VASc risk score. Points are added for each of the following it they apply to you:
Congestive heart failure with a recent exacerbation (1 point).
médicament antagoniste des récepteurs Hypertension - past or present (1 point).
Aged 75 years or older (2 points).
Diabetes (1 point).
Past history of a Stroke ou accident ischémique transitoire (2 points).
Vascular disease - for example, maladie artérielle périphérique, l'angine de poitrine or previous crise cardiaque (1 point).
Age 65-74 years (1 point).
Sex category (ie female sex scores 1 point and male scores 0).
The higher the total points score, the higher the risk of stroke. Everyone with a score of 2 or more should be treated with anticoagulation. Men with a risk of 1 may be offered anticoagulation. Women with a risk of 1 (in other words, where female sex is their only risk factor) are not offered anticoagulation because the benefits of treatment are likely to be outweighed by the risks.
Another risk score called the HAS-BLED score is used to estimate the risk of major bleeding when you are taking a medicine to reduce the risk of stroke if you have AF. This helps to decide whether or not steps should be taken to reduce your risk of bleeding if you take anticoagulation.
A risk score called ORBIT can be used to assess your risk of major bleeding, including bleeding into the brain. For most people, the benefit of anticoagulation outweighs the bleeding risk. However, if your bleeding risk is high and cannot be reduced, your doctor will discuss the pros and cons of starting (or stopping) anticoagulation.
The National Institute for Health and Care Excellence (NICE) advises that the ORBIT risk score should be used instead of HAS-BLED to assess the risk of major bleeding when starting blood-thinning medication and whilst you are on it. This is because the evidence shows that it has a higher accuracy in predicting the risk of bleeding than other bleeding risk tools.
The CHA2DS2-VASc stroke risk score and ORBIT bleeding risk score should be reassessed at least annually.
Which medicines help to reduce the risk of stroke?
Aspirine is very effective at reducing the risk of a second stroke if you have had a stroke which was not due to AF. However, where AF-related stroke is concerned, aspirin is much less effective than other treatments but just as likely to cause problems. It is therefore no longer recommended to reduce the risk of stroke in AF.
Instead, your doctor is likely to recommend an anticoagulant. In the past, warfarine was the traditional option. However, several newer agents called direct-acting oral anticoagulants (DOACs) are now available. These are called:
Studies have shown the DOACs to be at least as effective as warfarin for reducing the risk of an AF-related stroke. In addition, they:
Carry a lower risk of bleeding into the brain.
Need much less frequent blood monitoring (you do not need regular INR blood clotting tests).
Have fewer interactions with other medications or food. These interactions could otherwise result in you being more prone to bleeding or clotting.
Do not require you to adjust the dose frequently dependent on your blood results, as warfarin does.
As a result, NICE has updated its guidance to recommend that DOACs should be offered in preference to warfarin. If you are already taking warfarin, your doctor may discuss changing you to treatment with a DOAC, depending on the results of your blood tests.
To find out more about these medicines, including the risks and benefits of the various alternatives, see the separate leaflet called Anticoagulants.
Chirurgie
An operation can be used to reduce the risk of stroke for people with AF. The operation is called left atrial appendage occlusion and closes a pouch in the heart, called the left atrial appendage.
NICE in the UK has recommended that left atrial appendage occlusion can be considered as a treatment option to reduce the risk of stroke in people with AF. However, it does carry risks. It is therefore reserved for people who are at high risk of stroke and who cannot take anticoagulants.
Sélections des patients pour Médicaments pour le cœur et le sang

Traitement et médicaments
Statines et autres médicaments hypolipémiants
Les statines agissent en bloquant l'action d'une certaine substance chimique (enzyme) nécessaire à la production de cholestérol, et en éliminant certaines formes de cholestérol du sang.
par Dr Rachel Hudson, MRCGP

Traitement et médicaments
Anticoagulants
Les anticoagulants sont des médicaments qui empêchent le sang de coaguler aussi rapidement ou aussi efficacement que la normale. Certaines personnes appellent les anticoagulants des "anticoagulants sanguins". Cependant, le sang n'est pas réellement rendu plus fin — il ne coagule simplement pas aussi facilement pendant que vous prenez un anticoagulant. Les anticoagulants sont utilisés pour traiter et prévenir la formation de caillots sanguins dans les vaisseaux sanguins, comme dans les artères ou les veines.
par Dr Doug McKechnie, MRCGP
Questions fréquemment posées
What is the primary reason atrial fibrillation increases stroke risk?
Atrial fibrillation (AF) can disrupt the normal blood flow within the heart chambers. This can lead to the formation of small blood clots. If one of these clots travels to the brain and blocks a smaller blood vessel, it can cut off blood supply and cause a stroke.
Are strokes caused by AF typically different from other types of strokes?
Strokes that occur due to atrial fibrillation tend to be more severe than strokes caused by other underlying health issues or conditions.
How often should my stroke and bleeding risk scores be checked?
Both the CHA2DS2-VASc stroke risk score and the ORBIT bleeding risk score should be re-evaluated by your doctor at least once a year.
Is it possible to reduce the risk of stroke surgically for AF patients?
Yes, an operation called left atrial appendage occlusion can be performed. This procedure closes a specific pouch in the heart to reduce stroke risk. It is generally considered for those at high risk of stroke who cannot take anticoagulant medications.
Lectures complémentaires et références
- Fibrillation auriculaire : diagnostic et gestion; Directive NICE (avril 2021 - dernière mise à jour juin 2021)
- Fibrillation auriculaire; NICE CKS, octobre 2024 (accès réservé au Royaume-Uni)
- Thoracoscopic exclusion of the left atrial appendage in atrial fibrillation (with or without other cardiac surgery) for the prevention of thromboembolism, NICE Interventional Procedure Guideline, June 2011
- WatchBP Home A pour détecter opportunément la fibrillation auriculaire lors du diagnostic et du suivi de l'hypertension; Orientation sur les technologies médicales NICE, janvier 2013
- Société Européenne de Cardiologie; Lignes directrices pour la gestion de la fibrillation auriculaire, 2020
- Isaew A, Adderley NJ, Ryan R, et al; Le traitement de la fibrillation auriculaire paroxystique dans les soins primaires au Royaume-Uni. Heart. 1er juin 2017. pii: heartjnl-2016-310927. doi: 10.1136/heartjnl-2016-310927.
À propos du critiqueVoir la biographie complète

Dr Hayley Willacy, FRCGP
Médecin généraliste, Auteur médical
MBChB (1992), DRCOG, DFFP, MRCOG (Part 1) MRCGP (2007), DFSRH (2013), MSc - medical education (2020)
Le Dr Hayley Willacy était médecin généraliste au NHS travaillant dans le nord-ouest de l'Angleterre, qui a pris sa retraite de la pratique clinique en 2022 après 30 ans.
Historique de l'article
Article également disponible en Anglais, Allemand, Espagnol, Français, Italien, Portugais, Hindi, Hébreu, Arabe, and Suédois.
Prochaine révision prévue : 18 déc. 2027
19 déc. 2024 | Dernière version
Partagez vos pensées ou expériences avec les autres dans notre communautés de patients.
Inscrivez-vous à la newsletter Patient
Votre dose hebdomadaire de conseils de santé clairs et fiables - rédigés pour vous aider à vous sentir informé, confiant et maître de la situation.
En vous abonnant, vous acceptez notre Politique de confidentialité. Vous pouvez vous désabonner à tout moment. Nous ne vendons jamais vos données.


